Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Status:
Recruiting
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of venetoclax combined with
CACAG regimen with the traditional "3+7" regimen in the treatment of newly diagnosed acute
myeloid leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese PLA General Hospital
Collaborators:
Air Force Military Medical University, China First Hospital of China Medical University People's Liberation Army (PLA) Strategic Support Force Characteristic Medical Center The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army The 960th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army The General Hospital of Northern Theater Command The General Hospital of Western Theater Command Yantai Yuhuangding Hospital